PanoramicaGraficoTecnicoNotizieSchermataTrader

Wave Life Sciences Ltd/  SG9999014716  /

NASDAQ
13/11/2024  22:00:00 Var. -0.2000 Volume Denaro22:25:02 Lettera22:25:02 Max Min
15.6900USD -1.26% 1.98 mill.
Fatturato: 25.18 mill.		 14.9900Quantità in denaro: 100 15.9900Quantità in lettera: 100 16.7100 15.6050
GlobeNewswire 12/08 Wave Life Sciences Receives FDA Rare Pediatric Disease Designation for WVE-N531 for the Treatment of...
GlobeNewswire 08/08 Wave Life Sciences Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 01/08 Wave Life Sciences Second Quarter 2024 Financial Results Scheduled for August 8, 2024
GlobeNewswire 25/06 Wave Life Sciences Announces Positive Results from Phase 1b/2a SELECT-HD Trial with First Clinical D...
GlobeNewswire 12/06 Wave Life Sciences Announces Upcoming Presentations Highlighting Novel siRNA Program in Obesity and ...
GlobeNewswire 30/05 Wave Life Sciences to Present at 2024 Jefferies Global Healthcare Conference
GlobeNewswire 09/05 Wave Life Sciences Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 09/05 Wave Life Sciences Announces Appointment of Dr. Erik Ingelsson as Chief Scientific Officer
GlobeNewswire 07/05 Wave Life Sciences to Present at 2024 RBC Capital Markets Global Healthcare Conference
GlobeNewswire 02/05 Wave Life Sciences First Quarter 2024 Financial Results Scheduled for May 9, 2024
GlobeNewswire 30/04 Wave Life Sciences Announces Approval of First Clinical Trial Application for RestorAATion-2 Trial o...
GlobeNewswire 23/04 Wave Life Sciences Announces Continued Momentum in GSK Collaboration and Advancements in siRNA and R...
GlobeNewswire 27/03 Wave Life Sciences to Present at Upcoming Investor Conferences
GlobeNewswire 06/03 Wave Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business...
GlobeNewswire 28/02 Wave Life Sciences Fourth Quarter and Full Year 2023 Financial Results Scheduled for March 6, 2024
GlobeNewswire 27/02 Wave Life Sciences Announces Upcoming Presentations at MDA Conference that Highlight Best-in-Class P...
GlobeNewswire 08/01 Wave Life Sciences Highlights Recent Achievements and Upcoming 2024 Milestones
GlobeNewswire 03/01 US Neurologists Optimistic Regarding the Huntington’s Disease Treatment Pipeline, Emphasizing Haltin...
GlobeNewswire 03/01 Wave Life Sciences to Present at 42nd Annual J.P. Morgan Healthcare Conference
GlobeNewswire 15/12/2023 Wave Life Sciences Announces Initiation of Dosing in Phase 2 FORWARD-53 Trial of WVE-N531 in Duchenn...
GlobeNewswire 07/12/2023 Wave Life Sciences Prices $100 Million Public Offering of Ordinary Shares
GlobeNewswire 06/12/2023 Wave Life Sciences Announces Proposed Public Offering of Ordinary Shares and Pre-Funded Warrants
GlobeNewswire 06/12/2023 Wave Life Sciences Announces Initiation of Dosing in RestorAATion Clinical Program Evaluating First-...
GlobeNewswire 28/11/2023 Codexis to Host Virtual KOL Event on its ECO Synthesis™ Platform and the Future of RNAi Therapeutics...
GlobeNewswire 22/11/2023 Wave Life Sciences to Present at 6ᵗʰ Annual Evercore ISI HealthCONx Conference